vs
Side-by-side financial comparison of IRONWOOD PHARMACEUTICALS INC (IRWD) and NACCO INDUSTRIES INC (NC). Click either name above to swap in a different company.
NACCO INDUSTRIES INC is the larger business by last-quarter revenue ($66.8M vs $47.7M, roughly 1.4× IRONWOOD PHARMACEUTICALS INC). IRONWOOD PHARMACEUTICALS INC runs the higher net margin — -4.8% vs -5.8%, a 1.0% gap on every dollar of revenue. On growth, NACCO INDUSTRIES INC posted the faster year-over-year revenue change (-5.2% vs -47.3%). Over the past eight quarters, NACCO INDUSTRIES INC's revenue compounded faster (11.9% CAGR vs -20.2%).
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
NACCO Industries, Inc. is an American publicly traded holding company, headquartered in Cleveland, Ohio. Through a portfolio of mining and natural resources businesses, the company operates under three business segments: Coal Mining, North American Mining, and Minerals Management. The Coal Mining segment operates surface coal mines under long-term contracts with power generation companies and an activated carbon producer pursuant to a service-based business model. The North American Mining se...
IRWD vs NC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $47.7M | $66.8M |
| Net Profit | $-2.3M | $-3.8M |
| Gross Margin | — | 18.0% |
| Operating Margin | 14.3% | 11.3% |
| Net Margin | -4.8% | -5.8% |
| Revenue YoY | -47.3% | -5.2% |
| Net Profit YoY | -200.9% | -150.8% |
| EPS (diluted) | $0.01 | $-0.53 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $47.7M | $66.8M | ||
| Q3 25 | $122.1M | $76.6M | ||
| Q2 25 | $85.2M | $68.2M | ||
| Q1 25 | $41.1M | $65.6M | ||
| Q4 24 | $90.5M | $70.4M | ||
| Q3 24 | $91.6M | $61.7M | ||
| Q2 24 | $94.4M | $52.3M | ||
| Q1 24 | $74.9M | $53.3M |
| Q4 25 | $-2.3M | $-3.8M | ||
| Q3 25 | $40.1M | $13.3M | ||
| Q2 25 | $23.6M | $3.3M | ||
| Q1 25 | $-37.4M | $4.9M | ||
| Q4 24 | $2.3M | $7.6M | ||
| Q3 24 | $3.6M | $15.6M | ||
| Q2 24 | $-860.0K | $6.0M | ||
| Q1 24 | $-4.2M | $4.6M |
| Q4 25 | — | 18.0% | ||
| Q3 25 | — | 13.0% | ||
| Q2 25 | — | 10.0% | ||
| Q1 25 | — | 14.7% | ||
| Q4 24 | — | 12.0% | ||
| Q3 24 | — | 11.7% | ||
| Q2 24 | — | 13.4% | ||
| Q1 24 | — | 13.2% |
| Q4 25 | 14.3% | 11.3% | ||
| Q3 25 | 61.8% | 8.8% | ||
| Q2 25 | 53.2% | -0.1% | ||
| Q1 25 | -70.7% | 11.7% | ||
| Q4 24 | 34.8% | 5.5% | ||
| Q3 24 | 28.0% | 31.9% | ||
| Q2 24 | 26.5% | 14.1% | ||
| Q1 24 | 14.7% | 8.9% |
| Q4 25 | -4.8% | -5.8% | ||
| Q3 25 | 32.8% | 17.3% | ||
| Q2 25 | 27.7% | 4.8% | ||
| Q1 25 | -90.9% | 7.5% | ||
| Q4 24 | 2.5% | 10.7% | ||
| Q3 24 | 4.0% | 25.4% | ||
| Q2 24 | -0.9% | 11.4% | ||
| Q1 24 | -5.6% | 8.6% |
| Q4 25 | $0.01 | $-0.53 | ||
| Q3 25 | $0.23 | $1.78 | ||
| Q2 25 | $0.14 | $0.44 | ||
| Q1 25 | $-0.23 | $0.66 | ||
| Q4 24 | $0.03 | $0.99 | ||
| Q3 24 | $0.02 | $2.14 | ||
| Q2 24 | $-0.01 | $0.81 | ||
| Q1 24 | $-0.03 | $0.61 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $215.5M | $49.7M |
| Total DebtLower is stronger | — | $100.8M |
| Stockholders' EquityBook value | $-261.8M | $429.2M |
| Total Assets | $396.9M | $661.2M |
| Debt / EquityLower = less leverage | — | 0.23× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $215.5M | $49.7M | ||
| Q3 25 | $140.4M | $52.7M | ||
| Q2 25 | $92.9M | $49.4M | ||
| Q1 25 | $108.5M | $61.9M | ||
| Q4 24 | $88.6M | $72.8M | ||
| Q3 24 | $88.2M | $63.1M | ||
| Q2 24 | $105.5M | $62.4M | ||
| Q1 24 | $121.5M | $61.8M |
| Q4 25 | — | $100.8M | ||
| Q3 25 | $199.5M | — | ||
| Q2 25 | $199.3M | — | ||
| Q1 25 | $199.2M | — | ||
| Q4 24 | $199.0M | $99.4M | ||
| Q3 24 | $198.8M | — | ||
| Q2 24 | $198.6M | $29.0M | ||
| Q1 24 | $398.3M | $28.4M |
| Q4 25 | $-261.8M | $429.2M | ||
| Q3 25 | $-264.2M | $426.4M | ||
| Q2 25 | $-308.2M | $413.1M | ||
| Q1 25 | $-334.1M | $409.1M | ||
| Q4 24 | $-301.3M | $404.9M | ||
| Q3 24 | $-311.3M | $397.3M | ||
| Q2 24 | $-321.7M | $384.1M | ||
| Q1 24 | $-330.5M | $381.6M |
| Q4 25 | $396.9M | $661.2M | ||
| Q3 25 | $396.1M | $637.6M | ||
| Q2 25 | $342.9M | $631.3M | ||
| Q1 25 | $327.2M | $634.2M | ||
| Q4 24 | $350.9M | $631.7M | ||
| Q3 24 | $389.5M | $597.4M | ||
| Q2 24 | $395.6M | $560.1M | ||
| Q1 24 | $438.8M | $538.0M |
| Q4 25 | — | 0.23× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.08× | ||
| Q1 24 | — | 0.07× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $74.6M | $11.4M |
| Free Cash FlowOCF − Capex | $74.6M | — |
| FCF MarginFCF / Revenue | 156.3% | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $127.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $74.6M | $11.4M | ||
| Q3 25 | $47.6M | $42.3M | ||
| Q2 25 | $-15.1M | $-7.8M | ||
| Q1 25 | $20.0M | $5.0M | ||
| Q4 24 | $15.2M | $25.2M | ||
| Q3 24 | $9.9M | $2.8M | ||
| Q2 24 | $33.5M | $4.1M | ||
| Q1 24 | $45.0M | $-9.8M |
| Q4 25 | $74.6M | — | ||
| Q3 25 | $47.6M | — | ||
| Q2 25 | $-15.1M | — | ||
| Q1 25 | $19.9M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $9.9M | — | ||
| Q2 24 | $33.4M | — | ||
| Q1 24 | $44.9M | — |
| Q4 25 | 156.3% | — | ||
| Q3 25 | 39.0% | — | ||
| Q2 25 | -17.7% | — | ||
| Q1 25 | 48.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 10.8% | — | ||
| Q2 24 | 35.4% | — | ||
| Q1 24 | 60.0% | — |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | 0.1% | — |
| Q4 25 | — | — | ||
| Q3 25 | 1.19× | 3.19× | ||
| Q2 25 | -0.64× | -2.39× | ||
| Q1 25 | — | 1.03× | ||
| Q4 24 | 6.74× | 3.33× | ||
| Q3 24 | 2.71× | 0.18× | ||
| Q2 24 | — | 0.68× | ||
| Q1 24 | — | -2.14× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IRWD
Segment breakdown not available.
NC
| Transferred Over Time | $42.7M | 64% |
| Transferred At Point In Time | $24.1M | 36% |
